239 related articles for article (PubMed ID: 4949310)
1. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
Koticha KK; Sane AB
Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
[No Abstract] [Full Text] [Related]
2. [2 cases of paucibacillary leprosy resistant to dapsone].
Janssens L
Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
[TBL] [Abstract][Full Text] [Related]
3. Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates.
Gelber RH; Rea TH; Murray LP; Siu P; Tsang M; Byrd SR
Arch Dermatol; 1990 Dec; 126(12):1584-6. PubMed ID: 2256685
[TBL] [Abstract][Full Text] [Related]
4. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
Karat AB
Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
[No Abstract] [Full Text] [Related]
5. Primary dapsone-resistant leprosy in San Francisco.
Gelber RH
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
[TBL] [Abstract][Full Text] [Related]
6. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
[No Abstract] [Full Text] [Related]
7. A statistical analysis of two chemotherapy trials in lepromatous leprosy. I. The response to therapy as measured by inoculation of mice.
Am J Trop Med Hyg; 1978 Sep; 27(5):1005-14. PubMed ID: 362950
[No Abstract] [Full Text] [Related]
8. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
9. Survey of primary dapsone-resistant leprosy.
Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC
Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049
[No Abstract] [Full Text] [Related]
10. Therapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.
Languillon J; Yawalkar SJ; McDougall AC
Int J Lepr Other Mycobact Dis; 1979 Mar; 47(1):37-43. PubMed ID: 376454
[No Abstract] [Full Text] [Related]
11. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
Levy L; Shepard CC; Fasal P
Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
[No Abstract] [Full Text] [Related]
12. Primary dapsone resistant leprosy in Nepal.
Samuel NM; Samuel S; Loudon J; Adiga RB
Indian J Lepr; 1984; 56(4):819-22. PubMed ID: 6398343
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients.
Silva MT; Macedo PM; Costa MH; Gonçalves H; Torgal J; David HL
Ann Microbiol (Paris); 1982; 133(1):75-92. PubMed ID: 7051933
[TBL] [Abstract][Full Text] [Related]
14. Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae.
McDougall AC; Rees RJ
Lepr Rev; 1973 Jun; 44(2):59-64. PubMed ID: 4582180
[No Abstract] [Full Text] [Related]
15. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
[TBL] [Abstract][Full Text] [Related]
16. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
[TBL] [Abstract][Full Text] [Related]
17. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
[No Abstract] [Full Text] [Related]
18. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
19. Secondary dapsone-resistant leprosy in Shanghai Municipality.
Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
[No Abstract] [Full Text] [Related]
20. Application of polymerase chain reaction for the detection of Mycobacterium leprae DNA in specimens from treated leprosy patients.
Rafi A; Donoghue HD; Stanford JL
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):42-7. PubMed ID: 7730718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
